{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-001579","form_type":"8-K","ticker":"TLPH","cik":"0001427925","company_name":"TALPHERA, INC.","filed_at":"2024-01-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.159204+00:00","generated_at":"2026-06-06T21:51:25.985560+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Talphera sells DSUVIA/DZUVEO royalty rights to XOMA for $8M upfront","bullets":["Sold rights to royalty and milestone payments from Vertical Pharma to XOMA for $8M cash.","Potential milestones up to $116.5M based on net sales; Talphera retains partial rights after stepdown.","Stepdown occurs when XOMA receives a minimum payment amount; specific amount not disclosed.","After stepdown: Talphera keeps 50% of DoD sales royalties and milestones; XOMA gets 100% non-DoD.","Agreement includes customary reps, warranties, and indemnification obligations."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-001579","json":"https://secwatch.observer/filing/0001437749-24-001579.json","markdown":"https://secwatch.observer/filing/0001437749-24-001579.md","text":"https://secwatch.observer/filing/0001437749-24-001579.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427925/000143774924001579/0001437749-24-001579-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427925/000143774924001579/acrx20240117_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T21:51:25.985560+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"27097c8b36f90c9a34652b99eee923947d9301f7","claim":"TALPHERA, INC. entered into Payment Interest Purchase Agreement with XOMA (US) LLC valued at $8 million (effective 2024-01-12).","evidence_excerpt":"On January 12, 2024, Talphera, Inc. (the “Company”) and XOMA (US) LLC (“XOMA”) entered into a Payment Interest Purchase Agreement (the “Purchase Agreement”) for the sale by the Company to XOMA, in exchange for $8 million, of the Company’s right, title and interest in and to certain amounts payable to the Company (collectively, the “Purchased Receivables”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1427925/000143774924001579/0001437749-24-001579-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"XOMA (US) LLC"},{"label":"Value","value":"$8 million"},{"label":"Effective","value":"2024-01-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}